Amrutanjan Health Care: FY26 Revenue at ₹502.55 Mn

Amrutanjan Health Care Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹2.90 per equity share. Mr. Ramaswami Krishnan was appointed as an Additional Director (Non-Executive Independent Director), and Mr. Muralidharan Swayambunathan was re-appointed as a Non-Executive Independent Director. The company also approved the rolling out of the revised Second Phase “ESOP 2”. Revenue from operations for the year ended March 31, 2026, stood at ₹502.55 Mn.